Dear Partners and Friends,
Our entry into a new phase of the COVID-19 pandemic and the implementation of vaccines make antibody testing and evaluation of SARS-CoV-2 immune status an important part of the testitng strategies.
Antibodies against SARS-CoV-2 are produced by B cells of the immune system in case of infection with the virus or vaccination. The main antigens they recognize are Spike Protein and Nucleocapsid Protein. However, a number of studies have shown that not all antibodies have neutralising activity against the virus.
During our upcoming webinar on February 5th, 2021, 02:00 PM, we will talk more about the different types of antibodies and tests:
1.Qualitative and Quantitative Assays
2.ELISA and Rapid tests
3.Neutralizing Antibody Assays
The platform on which the webinar will take place will be further specified. Follow our information channels and contact us if you have any questions.
The RIDACOM team